2022 UK Interdisciplinary Breast Cancer Symposium

Don’t forget to register for the 2022 UK Interdisciplinary Breast Cancer Symposium to be held on-line on Monday 24 January and Tuesday 25 January.

Registration for this meeting is free.

You can find the up to date programme and details of faculty speakers on the UKIBCS website www.ukibcs.org.   You can also download the UKIBCS app from your app store.

We will have a single stream of presentations, where we will hear from speakers from the UK and beyond on the latest developments in these areas:

  • Prevention and early diagnosis
  • Early breast cancer – diagnosis and local treatment
  • Early breast cancer – systemic treatment
  • Metastatic breast cancer treatment
  • Translational and basic science
  • Living with and beyond breast cancer
  • The future of cancer services and research

 

The UKIBCS is a multidisciplinary meeting and we look forward to welcoming all delegates with an active interest in breast cancer research and treatment.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article